Feeds › Clinical trial updates
Clinical trial updates
Drug and device trials that companies register on ClinicalTrials.gov: newly completed phase 3 studies, changes of status and the dates a study is due to finish.
About this data
- What it is
- ClinicalTrials.gov is the US registry of clinical studies. Drug and device makers register their trials there and update the record as each study moves on. We list the studies that companies sponsor, and match the sponsor to a public company when the name lines up. The page opens on Phase 3 studies marked completed, the late-stage trials that come before a request for approval. Change View to see the changes of status we have noticed, or every recent update.
- Who files it
- The sponsor of the study, in its record on ClinicalTrials.gov. The registry is run by the US National Library of Medicine and does not check what sponsors report.
- How current
- We check the registry every day. Sponsors update records on their own schedule, from the same week to months later, so a change can appear in the registry well after it happened.
- Terms
- ClinicalTrials.govClinicalTrials.gov is the US government's registry of clinical studies, run by the National Library of Medicine. Sponsors register a study before it starts and update the record as it goes. The registry does not check what a sponsor reports.Phase 3The late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.statusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).completedThe sponsor has marked the study as finished. It says nothing about whether the treatment worked: results, if any, are reported separately and often later.status changesOur history of status changes starts the day we first stored each study, so a change made before that is not shown. The date is when we noticed the change, which can be later than when the sponsor made it.primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.company matchWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.
- Worth knowing
- A completed study is not a result: the registry says the study ended, not whether the treatment worked. Status changes start on the day we first stored each study, so earlier changes are not shown. Dates are the sponsor's own, and an estimated date can pass without an update. We match sponsors to companies automatically, with a hand-checked list for the large drugmakers, so a study with no ticker may still belong to a public company. This is information about studies, not a forecast of what they will show or of a stock's price.
- Not to be confused with
- FDA approvals and clearances: what the FDA decided, not what a sponsor reports about a study.
All of this comes from ClinicalTrials.gov, the US registry of clinical studies. We are not affiliated with it.
Source and freshness · Information, not investment advice (disclaimer).
Studies updated per day, last 30 days
All industry-sponsored studies Sponsor matched to a public company
By the day the sponsor last updated the study's record. A study updated twice counts once, on its latest day.
Latest clinical trial updates
Showing: ticker SVA · All recent updates
Studies by the date their record was last updated.
| Updated | Study | SponsorWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private. | PhaseThe late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages. | StatusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time). | Enrolled | Primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update. | Source |
|---|---|---|---|---|---|---|---|
| Nov 10, 2026 | Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women NCT07211152 · Influenza Participants will receive one dose of vaccine (0.5 mL) of S… | SVA Sinovac Biotech Co., Ltd | Phase 3 | Completed | 150 | Jun 26, 2026 | Registry ↗ |
| Oct 22, 2026 | Study on the Long-Term Persistence of Immunity Induced by Inactivated Hepatitis A Vaccine NCT07889219 · Hepatitis A Healive®, Havrix® | SVA Sinovac Biotech Co., Ltd | — | Recruiting | 106 | Nov 30, 2026 | Registry ↗ |
| Oct 22, 2026 | Phase I Clinical Trial of Trivalent Inactivated Split Influenza Virus Vaccine (MDCK Cell) NCT07889193 · Seasonal Influenza Cell-based Trivalent Split Influenza Virus Vaccine (cTIV),… | SVA Sinovac Biotech Co., Ltd | Phase 1 | Not yet recruiting | 175 | Dec 2026 | Registry ↗ |
| Oct 2, 2026 | A Study to Evaluate the 17-Year Immune Persistence of a Single Dose of Inactivated Hepatitis A Vacc… NCT07855705 · Hepatitis A Inactivated HAV vaccine, Attenuated live HAV vaccine | SVA Sinovac Biotech Co., Ltd | — | Completed | 105 | Mar 9, 2026 | Registry ↗ |
| Sep 23, 2026 | Phase I Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose) NCT07737106 · Influenza Influenza Vaccine (Split Virion), Inactivated (High Dose),… | SVA Sinovac Biotech Co., Ltd | Phase 1 | Completed | 50 | Sep 18, 2025 | Registry ↗ |
| Sep 21, 2026 | A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Wome… NCT07832201 · Influenza Anflu®, Vaxigrip® | SVA Sinovac Biotech Co., Ltd | Phase 4 | Not yet recruiting | 150 | Feb 2027 | Registry ↗ |
| Sep 1, 2026 | Bridging Clinical Trial of EV71 Vaccine in Vietnamese Children NCT07793175 · Hand, Foot, and Mouth Disease (HFMD), Enterovirus 71 Infect… EV71 vaccine | SVA Sinovac Biotech Co., Ltd | Not applicable | Not yet recruiting | 320 | Jan 9, 2027 | Registry ↗ |
| Aug 28, 2026 | Phase Ⅲ Clinical Trial of an Inactivated Hepatitis A Vaccine NCT07793227 · Hepatitis A Vaccine Inactivated Hepatitis A Vaccine (Human Diploid Cell) (1 mL)… | SVA Sinovac Biotech Co., Ltd | Phase 3 | Recruiting | 680 | Sep 15, 2027 | Registry ↗ |
| Aug 10, 2026 | Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years NCT07505888 · Epidemic Meningitis, Meningococcal Vaccines experimental vaccine, active comparator vaccine | SVA Sinovac Biotech Co., Ltd | Phase 3 | Active, not recruiting | 660 | Nov 2026 | Registry ↗ |
| Aug 10, 2026 | Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months NCT07505836 · Epidemic Meningitis, Meningococcal Vaccines experimental vaccine, Active Comparator vaccine | SVA Sinovac Biotech Co., Ltd | Phase 3 | Recruiting | 1,040 | Jan 2027 | Registry ↗ |
| Aug 10, 2026 | Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months NCT07505823 · Epidemic Meningitis, Meningococcal Vaccines experimental vaccine, Active Comparator vaccine | SVA Sinovac Biotech Co., Ltd | Phase 3 | Recruiting | 1,040 | Apr 2027 | Registry ↗ |
| Aug 10, 2026 | Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months NCT07505810 · Epidemic Meningitis, Meningococcal Vaccines experimental vaccine, Active Comparator vaccine | SVA Sinovac Biotech Co., Ltd | Phase 3 | Recruiting | 880 | Apr 2027 | Registry ↗ |
| Jun 26, 2026 | Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial NCT06063057 · Hand, Foot and Mouth Disease, Herpangina low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactiva… | SVA Sinovac Biotech Co., Ltd | Phase 1/2 | Completed | 744 | Dec 19, 2025 | Registry ↗ |
| May 28, 2026 | Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine… NCT07611513 · Hand, Foot, and Mouth Disease(HFMD), Herpangina Tetravalent Inactivated Enterovirus Vaccine (Vero Cell), Pl… | SVA Sinovac Biotech Co., Ltd | Phase 3 | Not yet recruiting | 6,000 | Dec 2027 | Registry ↗ |
| Mar 9, 2026 | Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Polio… NCT07457060 · Poliomyelitis 2wIPV+1sIPV, 1wIPV+2sIPV | SVA Sinovac Biotech Co., Ltd | Phase 4 | Recruiting | 480 | Sep 8, 2026 | Registry ↗ |
| Mar 4, 2026 | Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell). NCT06754384 · Hand, Foot, and Mouth Disease (HFMD), Herpangina Low-dose of tetravalent inactivated enterovirus vaccine (Ve… | SVA Sinovac Biotech Co., Ltd | Phase 1/2 | Completed | 552 | Dec 30, 2025 | Registry ↗ |
| Feb 18, 2026 | Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine NCT07418229 · RSV, mRNA Vaccine Low-dose RSV mRNA vaccine, High-dose RSV mRNA vaccine | SVA Sinovac Biotech Co., Ltd | Phase 1 | Not yet recruiting | 60 | Jun 30, 2026 | Registry ↗ |
| Feb 17, 2026 | Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine NCT07416110 · Rabies (Healthy Volunteers) Sinovac rabies vaccine | SVA Sinovac Biotech Co., Ltd | Phase 3 | Not yet recruiting | 912 | Sep 30, 2026 | Registry ↗ |
| Feb 10, 2026 | Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine NCT07400003 · Herpes Zoster, mRNA Vaccine Low-dose experimental vaccine, High-dose experimental vacci… | SVA Sinovac Biotech Co., Ltd | Phase 1/2 | Recruiting | 519 | May 31, 2026 | Registry ↗ |
| Jan 22, 2026 | Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried NCT07357545 · Rabies (Healthy Volunteers) Sinovac rabies vaccine, Marketed rabies vaccine | SVA Sinovac Biotech Co., Ltd | Phase 3 | Completed | 2,040 | Sep 21, 2022 | Registry ↗ |
| Jan 21, 2026 | Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations NCT07354269 · Poliomyelitis sIPV, DTaP-IPV-Hib | SVA Sinovac Biotech Co., Ltd | Phase 4 | Recruiting | 180 | Apr 11, 2026 | Registry ↗ |
| Jan 16, 2026 | Booster Dose of sIPV Co-administered With MMR and HepA-I. NCT06442449 · Poliomyelitis sIPV, MMR | SVA Sinovac Biotech Co., Ltd | Phase 4 | Completed | 889 | Sep 10, 2025 | Registry ↗ |
| Dec 18, 2025 | A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vacc… NCT05850364 · Poliomyelitis, Polio Sabin Strain Inactivated Poliovirus Vaccine | SVA Sinovac Biotech Co., Ltd | Phase 3 | Completed | 1,442 | Feb 13, 2025 | Registry ↗ |
| Aug 14, 2025 | A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months NCT06049927 · Seasonal Influenza Quadrivalent influenza vaccine(0.25ml), Quadrivalent influe… | SVA Sinovac Biotech Co., Ltd | Phase 3 | Completed | 3,300 | May 23, 2024 | Registry ↗ |
| Jul 17, 2025 | A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target P… NCT07071701 · Pneumococcal Infectious Disease 23-valent pneumococcal polysaccharide vaccine, Influenza va… | SVA Sinovac Biotech Co., Ltd | — | Completed | 19,267 | Apr 5, 2024 | Registry ↗ |
| Jul 9, 2025 | Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Pro… NCT07055893 · Rabies (Healthy Volunteers) Rabies vaccine, Verorab® | SVA Sinovac Biotech Co., Ltd | Phase 3 | Not yet recruiting | 390 | Jan 30, 2027 | Registry ↗ |
| Jul 9, 2025 | Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell) NCT07055880 · Rabies Rabies Vaccine (Serum-free Vero Cell), Freeze-dried, Verora… | SVA Sinovac Biotech Co., Ltd | Phase 2 | Not yet recruiting | 120 | Jan 15, 2026 | Registry ↗ |
| Jul 8, 2025 | Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Re… NCT07055295 · Rabies Rabies Vaccine (Serum-free Vero Cell), Freeze-dried, Verora… | SVA Sinovac Biotech Co., Ltd | Phase 3 | Not yet recruiting | 390 | Dec 30, 2026 | Registry ↗ |
| Jun 18, 2025 | Clinical Trial for Batch Consistency of EV71 Vaccine NCT07026500 · EV71 Vaccine EV71 Vaccine | SVA Sinovac Biotech Co., Ltd | Phase 4 | Completed | 720 | Apr 30, 2020 | Registry ↗ |
| Mar 14, 2025 | Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Diffe… NCT06346834 · Poliomyelitis sIPV | SVA Sinovac Biotech Co., Ltd | Phase 4 | Completed | 200 | Sep 6, 2024 | Registry ↗ |
| Jan 1, 2025 | Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell) NCT06734832 · Hand, Foot, and Mouth Disease(HFMD) bivalent enterovirus vaccine (Vero cell), inactivated, Ente… | SVA Sinovac Biotech Co., Ltd | Phase 3 | Recruiting | 8,000 | Nov 30, 2025 | Registry ↗ |
| Aug 21, 2024 | Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old NCT06058416 · Hepatitis A Healive (hepatitis A vacine(human diploid cell), inactivate… | SVA Sinovac Biotech Co., Ltd | Phase 4 | Active, not recruiting | 1,092 | Mar 17, 2028 | Registry ↗ |
| May 28, 2024 | Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent NCT05431725 · Seasonal Influenza Influenza Vaccine (Split Virion), Inactivated, Quadrivalent… | SVA Sinovac Biotech Co., Ltd | Phase 3 | Completed | 2,202 | Jul 19, 2023 | Registry ↗ |
| May 28, 2024 | A Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months NCT05245552 · Seasonal Influenza Quadrivalent influenza vaccine(0.25ml), Quadrivalent influe… | SVA Sinovac Biotech Co., Ltd | Phase 3 | Completed | 217 | Aug 4, 2023 | Registry ↗ |
| Apr 15, 2024 | Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency… NCT05386810 · Poliomyelitis Experimental vaccine, IPV control vaccine | SVA Sinovac Biotech Co., Ltd | Phase 3 | Completed | 1,572 | Oct 8, 2022 | Registry ↗ |
| Feb 9, 2024 | Active Case Finding of Clinical Hand Foot Mouth Disease in Children Aged 6 Months Old to 18 Years O… NCT06251219 · Hand, Foot and Mouth Disease PCR | SVA Sinovac Biotech Co., Ltd | — | Unknown | 100 | Jun 30, 2025 | Registry ↗ |
| Jan 17, 2024 | The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior Hig… NCT06208683 · Mumps, Influenza Mumps vaccine, Live (MV), Influenza Vaccine, inactivated, q… | SVA Sinovac Biotech Co., Ltd | Phase 4 | Unknown | 400 | Feb 2, 2024 | Registry ↗ |
| Oct 31, 2023 | A Serosurvey Study of Hand, Foot, and Mouth Disease in Indonesia NCT05637229 · Hand, Foot and Mouth Disease | SVA Sinovac Biotech Co., Ltd | — | Completed | 600 | Dec 19, 2022 | Registry ↗ |
| Oct 26, 2023 | Immunogenicity of After Primary Immunization and Booster Immunization of sIPV NCT06058429 · Polio no intervention | SVA Sinovac Biotech Co., Ltd | — | Unknown | 233 | Sep 7, 2023 | Registry ↗ |
| Sep 18, 2023 | Lot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide Vaccine NCT05731115 · Pneumococcal Infections Experimental 23-valent Pneumococcal | SVA Sinovac Biotech Co., Ltd | Phase 4 | Completed | 1,800 | May 5, 2023 | Registry ↗ |
| Sep 18, 2023 | Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), Inactivated NCT05512494 · Seasonal Influenza Quadrivalent Influenza Vaccine (Split Virion), inactivated | SVA Sinovac Biotech Co., Ltd | Phase 4 | Completed | 1,260 | Jan 24, 2023 | Registry ↗ |
| Sep 18, 2023 | Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine NCT05477693 · Pneumococcal Infections Experimental 23-valent PPV, Control 23-valent PPV | SVA Sinovac Biotech Co., Ltd | Phase 4 | Completed | 1,800 | Apr 10, 2023 | Registry ↗ |
| Jan 12, 2023 | A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants NCT05432141 · Poliomyelitis sIPV vaccine /DTaP vaccine, sIPV vaccine /Hepatitis A inact… | SVA Sinovac Biotech Co., Ltd | Phase 4 | Completed | 3,200 | Sep 13, 2022 | Registry ↗ |
| Jan 12, 2023 | An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses NCT04989231 · Poliomyelitis Investigational sIPV, Control IPV | SVA Sinovac Biotech Co., Ltd | — | Completed | 450 | Dec 25, 2022 | Registry ↗ |
| Aug 12, 2022 | A Study of Booster Immunization With COVID-19 Vaccine,Inactivated Co -Administration With Influenza… NCT05499351 · COVID-19 Adult group in immunogenicity and safety study of combined… | SVA Sinovac Biotech Co., Ltd | Phase 4 | Completed | 3,000 | Dec 5, 2021 | Registry ↗ |
| Aug 12, 2022 | A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine NCT04989465 · Pneumococcal Infections Investigational 23-valent PPV, Control 23-valent PPV | SVA Sinovac Biotech Co., Ltd | Phase 4 | Completed | 600 | Sep 13, 2021 | Registry ↗ |
| Aug 11, 2022 | Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (V… NCT05107557 · COVID-19 Experimental Group | SVA Sinovac Biotech Co., Ltd | Phase 4 | Completed | 520 | Dec 5, 2021 | Registry ↗ |
| Aug 11, 2022 | A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old NCT04997239 · Seasonal Influenza Two doses of quadrivalent influenza vaccine, One dose of qu… | SVA Sinovac Biotech Co., Ltd | Phase 4 | Completed | 600 | Oct 30, 2021 | Registry ↗ |
| Jul 25, 2022 | Study on Combined Vaccination With Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Polysa… NCT05471531 · Influenza and Pneumonia Combined vaccination with quadrivalent influenza vaccine an… | SVA Sinovac Biotech Co., Ltd | Phase 4 | Completed | 3,000 | Mar 10, 2022 | Registry ↗ |
| Jul 11, 2022 | Safety Observation of Enterovirus 71 Inactivated Vaccine (Vero Cell) Combined Immunization in Shang… NCT05166044 · Hand, Foot and Mouth Disease EV71 Inactivated Vaccine | SVA Sinovac Biotech Co., Ltd | — | Unknown | 12,500 | Jun 4, 2022 | Registry ↗ |
The newest 50 items, most recent first. Each row links to the study's page on ClinicalTrials.gov. Updated Nov 15, 2026, 7:30 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · FDA approvals and clearances